Patent · US Active

Process for producing L-arginine, L-ornithine or L-citrulline

US7741081B2 · kind B2 · utility

0Cited by
1References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 28, 2005
Grant dateJun 22, 2010
Priority date
Expiry dateJan 4, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y207/02008
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides a polypeptide which has: (i) an amino acid sequence wherein one or more amino acid residues are substituted in the region at positions 20 to 38 from the N terminus of the amino acid sequence shown in SEQ ID NO: 1; or (ii) an amino acid sequence wherein one or more amino acid residues are substituted in the region at positions 20 to 38 from the N terminus of the amino acid sequence shown in SEQ ID NO: 1 and one or more amino acid residues are deleted, substituted or added in the region at positions 1 to 19 or 39 to 294; and which has N-acetylglutamate kinase activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.